INS and type 2 diabetes mellitus: Our study has potential clinical significance, because it may be beneficial for the use of medications such as metformin and GLP-1 receptor agonists in T2DM patients receiving insulin therapy, which can be regarded as insulin sensitisers and insulin sparing drugs to reduce the risk of atherosclerotic lesions and its complications.